Alamar Biosciences joins forces with SciLifeLab to advance understanding of human disease

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Alamar-SciLifeLab

More Like This

GlobeNewswire associated0

Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research

PR Newswire associated0

Alamar Biosciences Launches Certified Service Provider Program to Expand Access to NULISA technology for Academic and Biopharmaceutical Researchers

PR Newswire associated0

Alamar Biosciences Announces Commercial Launch of the ARGO™ HT System and the NULISAseq™ Inflammation Panel 250 for Ultra-high Sensitivity Protein Analysis in Biofluids

PR Newswire associated0

Alamar Biosciences Achieves ISO 13485 Certification, Demonstrating its Commitment to Quality and Safety

PR Newswire associated0

Alamar Biosciences Establishes European Headquarters and Distribution Center in Milan, Italy

PR Newswire associated0

Alamar Biosciences Announces the Launch of the NULISAseq Mouse Panel 120

PR Newswire associated0

Alamar Biosciences launches the NULISAqpcr™ Custom Assay Development Kit to advance the development of novel biomarker assays for clinical research

PR Newswire associated0

Alamar Biosciences Announces the Commercial Launch of Ultra-high Sensitivity NULISAseq™ CNS Disease Panel 120 and NULISAqpcr™ pTau-217 Assays